Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
Recruiting · NCT06497595 · Registry updated 2026-07-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide | Atrophy, Body Weight, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-07-21 | NCT06497595 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hadassah Medical Organization | 53 |
| Sheba Medical Center | 63 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hadassah Medical Center | Jerusalem | Israel | 1 |
| Sheba medical center | Ramat Gan | Israel | 3 |